TNF Receptors in Murine Candida albicans Infection: Evidence for an Important Role of TNF Receptor p55 in Antifungal Defense

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2155-2159

  Steinshamn, Sigurd ^a   Bemelmans, Marc H A ^b   Van Tits, Lambertus J H ^b   Bergh, Kåre ^c   Buurman, Wim A ^b   Waage, Anders ^a  

^a University Medical Center   (Norway)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; C57BL MOUSE; CANDIDA ALBICANS; CANDIDIASIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; KINETICS; MORTALITY; MOUSE; MOUSE MUTANT; PATHOGENICITY; SOLUBILITY;

ANIMALS; ANTIBODIES, MONOCLONAL; CANDIDA ALBICANS; CANDIDIASIS; IMMUNITY, NATURAL; KINETICS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY;

EID: 0030240764     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tracey, K. J. 1994. Tumour necrosis factor-alpha. In The Cytokine Handbook, 2nd Ed. A. Thomson, ed. Academic Press, London, p. 289.
2. Beutler, B., I. W. Milsark, and A. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229:869.
3. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by human recombinant cachectin Science 330:662.
4. Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148:2724.
5. Djeu, J. Y., D. K. Blanchard, D. Halkias, and H. Friedman. 1986. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J. Immunol. 137:2980.
6. Steinshamn, S., and A. Waage. 1992. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60:4003.
7. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894.
8. Engelmann, H., H. Holtmann, C. Brakebusch, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497.
9. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor necrosis factor-binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265:1531.
10. Brockhaus, M., H.-J. Schoenfeld, E.-J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:3127.
11. Gatananga, T., C. D. Hwang, W. Kohr, F. Cappucino, J. A. Lucci, E. W. Jeffes, R. Lentz, J. Tomich, R. S. Yamamoto, and G. A. Granger. 1990. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc. Natl. Acad. Sci. USA 87:8731.
12. Lantz, M., U. Gullberg, E. Nilsson, and I. Olsson. 1990. Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J. Clin. Invest. 86:1396.
13. Seckinger, P., J. H. Zhang, B. Hauptmann, and J. M. Dayer. 1990. Characterization of a human tumor necrosis fuctor-α (TNF-α) inhibitor: evidence of immunological cross-reactivity with the TNF-receptor. Proc. Natl. Acad. Sci. USA 87:5188.
14. Spinas, G. A., U. Keller, and M. Brockhaus. (1992) Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J. Clin. Invest. 90:533.
15. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:4845.
16. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323.
17. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
18. Camerini, D., G. Walz, W. A. M. Loenen, J. Borst, and B. Seed. 1991. The T cell activation antigen CD27 is a member of the nerve growth/tumor necrosis factor gene family. J. Immunol. 147:3165.
19. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. W. Wong, E. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830.
20. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. Zinkernagel, M. Steinmmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF mediated toxicity, but highly susceptible to infection by Liberia monocytogenes. Nature 364:798.
21. Pfeffer, K., T. Matsuyama, T. M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegman, P. S. Ohasi, M. Krönke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
22. Schiut, K. E. 1979. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect. Immun. 24:932.
23. Bodey, G. P., M. Buckley, Y. S. Sathe, and E. J. Freireich. 1966. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64:328.
24. Odds, F. C. 1988. Ecology of Candida and epidemiology of candidosis, In Candida and Candidosis, 2nd Ed. Baillere-Tindall, London, p. 68.
25. Bodey, G. P. 1984. Candidiasis in cancer patients. Am. J. Med. 77:13.
26. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. F. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560.
27. Rogers, T., and E. Balish. 1976. Experimental Candida albicans infection in conventional mice and germ free rats. Infect. Immun. 14:33.
28. Hurtrel, B., P. H. Lagrange, and J.-C. Michel. 1980. Systemic candidiasis in mice. I. Correlation between kidney infection and mortality rate. Ann. Immunol. (Inst. Pasteur) 131C:105.
29. Sheehan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutrulize murine tumor necrosis factor. J. Immunol. 142:3884.
30. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEH1 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
31. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
32. Bemelmans, M. H. A., D. J. Gouma, and W. A. Buurman. 1993. LPS-induced sTNFR-releasc in vivo in a murine model: investigation of the role of tumor necrosis factor, IL-1, leukemia inhibitor factor and IFN-γ. J. Immunol. 151:5554.
33. Allendoerfer, R., D. M. Magee, J. G. Smith, L. Bonewald, and J. R. Graybill. 1993. Induction of tumor necrosis factor-α in murine Candida albicans infection. J. Infect. Dis. 167:1168.
34. Louie, A., A. L. Baltch, R. P. Smith, M. A. Franke, W. J. Ritz, J. K. Singh, and M. A. Gordon. 1994. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect. Immun. 62:2761.
35. Steinshamn, S., M. H. A. Bemelmans, W. A. Buurman, and A. Waage. 1995. Granulocytopenia reduces release of soluble TNFR receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity. Cytokine 7:50.